Humanoid, Inc. (HERB)
OTCMKTS
· Delayed Price · Currency is USD
0.0350
+0.0130 (59.09%)
Jun 2, 2025, 1:25 PM EDT
Humanoid Revenue
In the year 2023, Humanoid had annual revenue of $21.14M with 13.71% growth. Humanoid had revenue of $229.26M in the quarter ending December 31, 2015, a decrease of -24.48%.
Revenue
21.14M
Revenue Growth
-97.75%
P/S Ratio
0.26
Revenue / Employee
86.27K
Employees
245
Market Cap
5.50M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 21.14M | 2.55M | 13.71% |
Dec 31, 2022 | 18.59M | 4.57M | 32.64% |
Dec 31, 2021 | 14.01M | 1.47M | 11.67% |
Dec 31, 2020 | 12.55M | -926.35M | -98.66% |
Dec 31, 2015 | 938.90M | -73.24M | -7.24% |
Dec 31, 2014 | Pro | Pro | Pro |
Dec 31, 2013 | Pro | Pro | Pro |
Dec 31, 2012 | Pro | Pro | Pro |
Dec 31, 2011 | Pro | Pro | Pro |
Dec 31, 2010 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Cordyceps Sunshine Biotech Holdings | 882.53K |
Cuisine Solutions | 80.48M |
Armanino Foods of Distinction | 69.40M |
South Dakota Soybean Processors, LLC | 524.07M |
ESG Inc. | 11.89M |
Pyxus International | 2.38B |
Crimson Wine Group | 71.52M |
Hongchang International | 2.87M |
Humanoid News
- 2 years ago - Yasheng Group Reports Financial Results for the First Quarter of 2023: - GlobeNewsWire
- 2 years ago - Rare Earth Elements Collected from Wastewater Utilizing Cyanobacteria Now Patent Pending - GlobeNewsWire
- 2 years ago - Yasheng Group Notifies FINRA of Plan to Pay Preferred Dividend to Common Shareholders - GlobeNewsWire
- 2 years ago - Yasheng's AI-Powered Cancer Therapy Patent Revolutionizes Immunotherapy Development - GlobeNewsWire